Labcorp Files 8-K for Regulatory Disclosure
Ticker: LH · Form: 8-K · Filed: May 8, 2024 · CIK: 920148
| Field | Detail |
|---|---|
| Company | Laboratory Corp Of America Holdings (LH) |
| Form Type | 8-K |
| Filed Date | May 8, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.10 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, sec-disclosure
Related Tickers: LH
TL;DR
Labcorp filed a standard 8-K, no major news.
AI Summary
Laboratory Corporation of America Holdings (Labcorp) filed an 8-K on May 8, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or new material events beyond the standard reporting requirements for this type of form.
Why It Matters
This filing indicates Labcorp is adhering to its reporting obligations with the SEC, providing transparency to investors about its corporate actions and financial information.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for regulatory disclosure and does not contain any new material information that would inherently increase risk.
Key Players & Entities
- Laboratory Corporation of America Holdings (company) — Registrant
- Labcorp (company) — Commonly known name for Registrant
- 0000920148-24-000034 (filing_id) — Accession Number
- May 8, 2024 (date) — Filing Date
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and Financial Statements and Exhibits, as indicated in the filing information.
What is the exact name of the registrant?
The exact name of the registrant is LABORATORY CORPORATION OF AMERICA HOLDINGS.
On what date was this 8-K filed?
This 8-K was filed on May 8, 2024.
What is the principal executive office address for Laboratory Corporation of America Holdings?
The principal executive office address is 358 South Main Street, Burlington, North Carolina 27215.
Does this filing report any specific new financial results or material events?
This filing does not appear to report specific new financial results or material events beyond the standard disclosure requirements for an 8-K, as it is categorized under 'Regulation FD Disclosure' and 'Financial Statements and Exhibits'.
Filing Stats: 423 words · 2 min read · ~1 pages · Grade level 11.5 · Accepted 2024-05-08 08:08:36
Key Financial Figures
- $0.10 — nge on which registered Common Stock , $0.10 par value LH New York Stock Exchange
Filing Documents
- lh-20240508.htm (8-K) — 24KB
- formpr2024shareholdermeeti.htm (EX-99.1) — 5KB
- lc2020logov2.gif (GRAPHIC) — 5KB
- 0000920148-24-000034.txt ( ) — 159KB
- lh-20240508.xsd (EX-101.SCH) — 2KB
- lh-20240508_lab.xml (EX-101.LAB) — 22KB
- lh-20240508_pre.xml (EX-101.PRE) — 12KB
- lh-20240508_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced that its Annual Meeting of Shareholders will be webcast live on May 14 at 9:00 a.m. ET and can be viewed online on the Labcorp Investor Relations website. An archived replay of the webcast will be available for one year.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit Exhibit Name Exhibit 99.1 Press release dated May 8, 2024 issued by Labcorp
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LABORATORY CORPORATION OF AMERICA HOLDINGS Registrant By: /s/ SANDRA VAN DER VAART Sandra van der Vaart Executive Vice President, Chief Legal Officer and Corporate Secretary May 8, 2024